Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan versus benazepril in Chinese patients with advanced heart failure
ChiCTR1800020423Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: cardiac death and rehospitalization due to heart failure. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR1800020423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020423.